Skip to content

Harrow HROW Common Stock

Common Stock at other companies

AbbVie logo
AbbVieABBV
$18M0.0%
Bausch + Lomb logo
Bausch + LombBLCO
$0
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$22K+37.5%
Viatris logo
ViatrisVTRS
3B
Bausch Health Companies logo
Bausch Health CompaniesBHC
$10.54B+0.3%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
200M0.0%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's common stock?
Harrow (HROW) reported common stock of 50M in Q1 2026.
How has Harrow's common stock changed year-over-year?
Harrow's common stock decreased by 0.0% year-over-year, from 50M to 50M.
What is the long-term trend for Harrow's common stock?
Over 5 years (2020 to 2025), Harrow's common stock has grown at a 0.0% compound annual growth rate (CAGR), from 50M to 50M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).